Literature DB >> 12767012

Molecular characterization of influenza B viruses circulating in northern Italy during the 2001-2002 epidemic season.

Filippo Ansaldi1, Pierlanfranco D'Agaro, Daniela De Florentiis, Simona Puzelli, Yi Pu Lin, Victoria Gregory, Michael Bennett, Isabella Donatelli, Roberto Gasparini, Pietro Crovari, Alan Hay, Cesare Campello.   

Abstract

During the 2001-2002 influenza season, virological surveillance highlighted the predominant circulation of B viruses (86% of isolates) in Italy, in contrast to many other countries in Europe and North America where AH3N2 viruses were isolated most frequently, and in contrast to the infrequent isolation of B viruses in Italy during the previous two years. Associated with this predominance of influenza B was the re-emergence of B/Victoria/2/87-lineage viruses, closely related to B viruses prevalent during the 1980s, which are distinct antigenically and genetically from circulating B/Sichuan/379/99-like viruses of the B/Yamagata/16/88 lineage, which predominated in most parts of the world during the last 10 years. Ninety-four viruses isolated in two regions of northern Italy were characterized, 50 by direct sequencing of haemagglutinin (HA). Viruses of both Victoria and Yamagata lineages co-circulated throughout the 12 weeks of the influenza season. The HAs of the Yamagata-lineage viruses were heterogeneous and comprised two sublineages, represented by B/Sichuan/379/99 and B/Harbin/7/94, whereas the Victoria-lineage viruses were more homogeneous and closely related to B/Hong Kong/330/01, the current prototype vaccine strain. The antigenic and genetic characteristics of the viruses correlated with certain epidemiological features. In particular, the low age (<14 years) of individuals infected with B/Hong Kong/330/01-like viruses is likely to reflect the greater susceptibility of the youngest cohort, due to lack of previous exposure to Victoria-lineage viruses, and is consistent with the conclusion that vaccination with a B/Sichuan/379/99-like virus would give poor protection against infection with B/Hong Kong/330/01-like (Victoria-lineage) viruses. Copyright 2003 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2003        PMID: 12767012     DOI: 10.1002/jmv.10418

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

1.  Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy.

Authors:  Filippo Ansaldi; Barbara Pastorino; Laura Valle; Paolo Durando; Laura Sticchi; Pierluigi Tucci; Paolo Biasci; Piero Lai; Roberto Gasparini; Giancarlo Icardi
Journal:  J Clin Microbiol       Date:  2006-12-13       Impact factor: 5.948

2.  Neutralizing and hemagglutination-inhibiting activities of antibodies elicited by the 2004-2005 influenza vaccine against drifted viruses.

Authors:  Filippo Ansaldi; Sabrina Bacilieri; Federica Banfi; Paolo Durando; Laura Sticchi; Giancarlo Icardi; Roberto Gasparini
Journal:  Clin Vaccine Immunol       Date:  2006-01

3.  Trends of influenza B during the 2010-2016 seasons in 2 regions of north and south Italy: The impact of the vaccine mismatch on influenza immunisation strategy.

Authors:  Andrea Orsi; Giuseppina Maria Elena Colomba; Fanny Pojero; Giuseppe Calamusa; Cristiano Alicino; Cecilia Trucchi; Paola Canepa; Filippo Ansaldi; Francesco Vitale; Fabio Tramuto
Journal:  Hum Vaccin Immunother       Date:  2017-08-03       Impact factor: 3.452

4.  Surveillance of influenza viruses in the post-pandemic era (2010-2012) in Northern Italy.

Authors:  Elena Pariani; Antonella Amendola; Alberto Ranghiero; Giovanni Anselmi; Alessandro Zanetti
Journal:  Hum Vaccin Immunother       Date:  2013-01-09       Impact factor: 3.452

5.  Increasing appearance of reassortant influenza B virus in Taiwan from 2002 to 2005.

Authors:  Huey-Pin Tsai; Hsuan-Chen Wang; David Kiang; Sheng-Wen Huang; Pin-Hwa Kuo; Ching-Chuan Liu; Ih-Jen Su; Jen-Ren Wang
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

6.  Ten years (2004-2014) of influenza surveillance in Northern Italy.

Authors:  Elena Pariani; Antonella Amendola; Alessandra Piatti; Giovanni Anselmi; Alberto Ranghiero; Laura Bubba; Anna Maria Rosa; Laura Pellegrinelli; Sandro Binda; Liliana Coppola; Maria Gramegna; Alessandro Zanetti
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

7.  Cocirculation and evolution of two lineages of influenza B viruses in europe and Israel in the 2001-2002 season.

Authors:  X Sherry Chi; Trentice V Bolar; Ping Zhao; Ruth Rappaport; Sheau-Mei Cheng
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Influenza epidemiology in Italy two years after the 2009-2010 pandemic: need to improve vaccination coverage.

Authors:  Roberto Gasparini; Paolo Bonanni; Daniela Amicizia; Antonino Bella; Isabella Donatelli; Maria Luisa Cristina; Donatella Panatto; Piero Luigi Lai
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

9.  Virological investigation of four outbreaks of influenza B reassortants in the northern region of Taiwan from October 2006 to February 2007.

Authors:  Yuan-Ming Lee; Sheng-Fan Wang; Cheng-Ming Lee; Kuan-Hsuan Chen; Yu-Jiun Chan; Wu-Tse Liu; Yi-Ming Arthur Chen
Journal:  BMC Res Notes       Date:  2009-05-09

10.  Integrating influenza antigenic dynamics with molecular evolution.

Authors:  Trevor Bedford; Marc A Suchard; Philippe Lemey; Gytis Dudas; Victoria Gregory; Alan J Hay; John W McCauley; Colin A Russell; Derek J Smith; Andrew Rambaut
Journal:  Elife       Date:  2014-02-04       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.